ECOLAB INC. for ECOLAB INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2025 | $390,000 | Replaced |
| 2nd Quarter - Amendment | Aug 6, 2025 | $430,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
Discussions related to environmental policies and issues including water infrastructure, water reuse, water efficiency, water resource management, and sustainability. Discussions related to energy and water efficiency initiatives. Discussions related to PFAS remediation technology. Discussions related to the implementation of the Pesticide Registration Improvement Act, P.L.117-103. Discussions related to data center water efficiency and energy efficiency.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JAMES R. BAILEY | — |
| LEA MCCABE | — |
Taxation/Internal Revenue Code TAX
Discussions regarding scope of Sec. 48D investment tax credit; Discussions related to the extension of the Tax Cuts and Jobs Act (P.L.115-97); H.R.1, One Big Beautiful Bill Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JAMES R. BAILEY | — |
| LEA MCCABE | — |
Trade (domestic/foreign) TRD
Discussions related to supply chain challenges. Discussions regarding trade policy and tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JAMES R. BAILEY | — |
| LEA MCCABE | — |
Energy/Nuclear ENG
Discussions regarding sustainable aviation fuel. Discussions regarding permitting reform. Discussions regarding Department of Energy programs for Critical Mineral production, including the use of resins as extraction technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JAMES R. BAILEY | — |
| LEA MCCABE | — |
Pharmacy PHA
Discussions regarding biopharmaceutical manufacturing policy. Discussions regarding resin bead manufacturing technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANY ATWELL | — |
| JAMES R. BAILEY | — |
| LEA MCCABE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.